| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |